Funding
← Back to your selection

abrdn

Activity from announced rounds

Activity in this selectionnomura-real-estate-development-co-f095adde
Rounds participated in
3
Confirmed lead rounds
—
3 roles undisclosed
New companies
3
First participation on record · 0 follow-on
Funding in participating rounds
$208M
3 disclosed · full round size, not this investor’s share

By stage

Series C+2
Series A1

By primary sector

Biotech3

By country

United States3

Rounds

3 in this selection
Abcuro

Clinical-stage immunotherapies targeting pathogenic cytotoxic T cells in autoimmune disease.

$66MSeries D
Role not disclosed
Third Arc Bio

Develops novel multifunctional antibodies for oncology and immunology & inflammation indications

$52MSeries A+
Role not disclosed